Mode
Text Size
Log in / Sign up

Retrospective cohort study of 74 patients with Chlamydia psittaci pneumonia identifies prognostic indicators and severity associations.

Retrospective cohort study of 74 patients with Chlamydia psittaci pneumonia identifies prognostic in…
Photo by National Cancer Institute / Unsplash
Key Takeaway
Note that severe CPP associates with prolonged hospitalization and specific imaging; D-dimer and lymphocyte % may aid severity assessment.

This retrospective cohort study analyzed the clinical course and prognostic factors in 74 patients diagnosed with Chlamydia psittaci pneumonia (CPP) via metagenomic (mNGS) and targeted next-generation sequencing (tNGS). The study compared clinical manifestations, laboratory findings, and imaging characteristics between non-severe and severe CPP groups to identify predictors of disease severity and outcomes. The specific setting and follow-up duration were not reported in the available data.

The analysis revealed that hospitalization duration was significantly longer in the severe group compared to the non-severe group, with a mean of 12.95 ± 6.08 days versus 8.13 ± 3.30 days (p < 0.05). Additionally, prolonged hospitalization, bilateral pulmonary infiltrates, and pleural effusion were identified as clinical features associated with severe CPP. While specific absolute numbers for these associations were not reported, the statistical significance of the hospitalization duration difference was noted.

Regarding prognostic indicators, the study highlighted that D-dimer levels and lymphocyte percentage are valuable for assessing disease severity. However, the study did not explicitly state a single primary outcome, focusing instead on comparing clinical features and prognostic factors between the two severity groups. Safety data, including adverse events or tolerability, were not reported in the provided evidence.

Key limitations include the retrospective study design, the unspecified single-center or setting, and a lack of information regarding external validation or generalizability. As an observational study, the results may be subject to confounding and bias inherent in retrospective designs. Consequently, causal relationships between the identified clinical features and disease severity cannot be definitively established based on this evidence alone.

In terms of practice relevance, the study suggests that while early targeted antibiotic therapy is effective, timely respiratory support remains critical for severe cases. Clinicians should interpret these findings with caution, recognizing that the associations identified require further prospective validation before they can be integrated into standard diagnostic or prognostic algorithms for CPP.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Chlamydia psittaci pneumonia (CPP) is frequently misdiagnosed and can progress to severe illness. A deeper understanding of its clinical and imaging features is crucial for early detection and effective treatment. This retrospective study analyzed 74 patients diagnosed with CPP via metagenomic (mNGS) and targeted next-generation sequencing (tNGS) between January 2022 and September 2025. Patients were categorized into severe (n = 21) and non-severe (n = 53) groups based on established criteria for severe community-acquired pneumonia. Data on demographics, clinical manifestations, laboratory findings, and imaging characteristics were collected and compared. The cohort had a median age of 60 years, with a male predominance (62.2%). A history of poultry/bird exposure was reported by 87.8% of participants. Common symptoms included fever (94.6%), cough (63.5%), and fatigue (29.7%), with no significant differences between groups. Hospitalization was significantly longer in the severe group (12.95 ± 6.08 days) than in the non-severe group (8.13 ± 3.30 days) (p  Severe CPP is associated with prolonged hospitalization, bilateral pulmonary infiltrates, and pleural effusion. D-dimer and lymphocyte percentage are valuable prognostic indicators for disease severity. Early targeted antibiotic therapy is effective, but timely respiratory support is critical for severe cases.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.